Individualizing the treatment approach in case of diabetes management based on factors such as age, health behaviors, comorbidities, and life expectancy, is recommended by the American Diabetes Association and the European Association for the Study of Diabetes . 1 Lilly and Docplexus have organized an interesting webinar on “A Patient Centered Approach with Rapid Acting Insulin” on 19th November 2019 , session 1 at 06:30 pm and session 2 at 10:30 pm onwards.
The objectives are as follows: To understand the main advantages of concentrated insulins therapeutic options for people with T2D To identify which patient profiles can benefit more for a therapeutic solution like rapid-acting insulin To discuss when in the treatment continuum of T2D , should rapid-acting insulin be considered a good therapeutic option To provide a platform to share clinical case experiences on the usage of…
